Aday JS, Mitzkovitz CM, Bloesch EK, Davoli CC, Davis AK (2020) Long-term effects of psychedelic drugs: a systematic review. Neurosci Biobehav Rev 113:179–189

Article  CAS  PubMed  Google Scholar 

Aday JS, Davis AK, Mitzkovitz CM, Bloesch EK, Davoli CC (2021) Predicting reactions to psychedelic drugs: a systematic review of states and traits related to acute drug effects. ACS Pharmacol Transl Sci 4(2):424–435

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agin-Liebes G, Malone T, Yalch MM, Mennenga SE, Ponte KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S (2020) Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J Psychopharmacol 34(2):155

Article  PubMed  Google Scholar 

Agin-Liebes G, Haas TF, Lancelotta R, Uthaug MV, Ramaekers JG, Davis AK (2021) Naturalistic use of mescaline is associated with self-reported psychiatric improvements and enduring positive life changes. ACS Pharmacol Transl Sci 4(2):543

Article  CAS  PubMed  PubMed Central  Google Scholar 

Belfrage LK (1975) The role of the concept of death in existential psychology: from Kierkegaard to Binswanger. Mast Thes & Spec Proj, p 2124

Blomstrom M, Burns A, Larriviere D, Penberthy JK (2020) Addressing fear of death and dying: traditional and innovative interventions. Mortality 27(1):18–37

Article  Google Scholar 

Carhart-Harris RL, Friston KJ (2019) REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71(3):316–344

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chavez-Baldini U, Verweij KJH, Bergamin J, Luigjes J, Mocking RJT, Denys D, Nieman DH, Vulink NC (2024) Existential concerns in psychopathology: a transdiagnostic network analysis existential concerns in psychopathology. Cogent Mental Health 3(1):1–23

Article  Google Scholar 

Cummins C, Lyke J (2013) Peak experiences of psilocybin users and non-users. J Psychoactive Drugs 45(2):189–194

Article  PubMed  Google Scholar 

David J, Bouso JC, Kohek M, Ona G, Tadmor N, Arnon T, Dor-Ziderman Y, Berkovich-Ohana A (2023) Ayahuasca-induced personal death experiences: prevalence characteristics and impact on attitudes toward death, life, and the environment. Front Psychiatry 14. https://doi.org/10.3389/fpsyt.2023.1287961

Davis AK, Clifton JM, Weaver EG, Hurwitz ES, Johnson MW, Griffiths RR (2020) Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: phenomenology, interpretation, and enduring effects. J Psychopharmacol 34(9)

Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR (2021) Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. J Psychopharmacol 35(4):437–446

Article  PubMed  PubMed Central  Google Scholar 

Doblin R (1991) Pahnke's Good Friday experiment: a long-term follow-up and methodological critique. J Transpersonal Psychol 23

Fisher G (1970) Psychotherapy for the dying: principles and illustrative cases with special reference to the use of LSD. Omega 1(1)

Gasser P, Kirchner K, Passie T (2015) LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects. J Psychopharmacol 29(1)

Gire J (2014) How death imitates life: cultural influences on conceptions of death and dying. Online Readings in Psychology and Culture 6(2)

Gonzalez D, Carvalho M, Cantillo J, Aixala M, Farre M (2019) Potential use of ayahuasca in grief therapy. Omega 79(3)

Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, Jesse R (2011) Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects experiences: immediate and persisting dose-related effects. Psychopharmacology 218(4):649–665

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA (2016) Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. J Psychopharmacol 30(12):1181–1197

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA (2018) Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. J Psychopharmacol 32(1)

Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, Jesse R (2019) Survey of subjective "God encounter experiences": comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLoS One 14(4)

Grof S (2008) LSD psychotherapy, 4th edn. Multidisciplinary Association for Psychedelic Studies

Grof S, Goodman LE, Richards WA, Kurland AA (1973) LSD-assisted psychotherapy in patients with terminal cancer. Int Pharmacopsychiatry 8(3)

Heidenreich T, Noyon A, Worrell M, Menzies R (2021) Existential approaches and cognitive behaviour therapy: challenges and potential. Int J Cogn Ther 14(1):209–234

Article  PubMed  PubMed Central  Google Scholar 

Iverach L, Menzies RG, Menzies RE (2014) Death anxiety and its role in psychopathology: reviewing the status of a transdiagnostic construct. Clin Psychol Rev 34(7):580–593

Article  PubMed  Google Scholar 

Kast E (1966) LSD and the dying patient. The Chicago Medical School Quarterly 26(2)

Kast E (1967) Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide. Psychiatr Q 41(4)

Kast EC, Collins VJ (1964) Study of lysergic acid diethylamide as an analgesic agent. Anesth Analg 43

Ko K, Knight G, Rucker JJ, Cleare AJ (2022) Psychedelics, mystical experience, and therapeutic efficacy: a systematic review. Front Psychiatry 13:917199

Article  PubMed  PubMed Central  Google Scholar 

Kurland AA, Grof S, Pahnke WN, Goodman LE (1972) Psychedelic drug-assisted psychotherapy in patients with terminal cancer. J Thanatol

Lawrence DW, Carhart-Harris R, Griffiths R, Timmermann C (2022) Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Sci Rep 12(1)

Leary T (1963) The religious experience: its production and interpretation. In: Leary T, Metzner R, Weil GM (eds)(1993) The psychedelic reader. Citadel Press, Carol publishing Group

Lehto RH, Stein KF (2009) Death Anxiety: An Analysis of an Evolving Concept. Res and the for Nurs Prac 23(1):23–41

Article  Google Scholar 

Lester D, Templer DI, Abdel-Khalek A (2007) A cross-cultural comparison of death anxiety: a brief note. Omega 54(3):255–260

Article  Google Scholar 

Maia LO, Daldegan-Bueno D, Tofoli LF (2021) The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study. J Psychoactive Drugs 53(3)

McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C (2016) PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidem 75:40–46

Article  Google Scholar 

Menzies R, Menzies R (2023) Death anxiety and mental health: requiem for a dreamer. J Behav Ther Exp Psychiatry 78

Michael P, Luke D, Robinson O (2023) An encounter with the self: a thematic and content analysis of the DMT experience from a naturalistic field study. Front Psychol 14

Moreton SG, Szalla L, Menzies RE, Arena AF (2020) Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics. Psychopharmacology 237(1):21–32

Article  CAS  PubMed  Google Scholar 

Moreton SG, Arena AF, Foy Y, Menzies RE (2023a) Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being. Death Studies 1–12.

Moreton SG, Burden-Hill A, Menzies R (2023b) Reduced death anxiety and obsessive beliefs as mediators of the therapeutic effects of psychedelics on obsessive compulsive disorder symptomology. Clin Psychol 27(1):58–73

Article  Google Scholar 

Mosurinjohn S, Roseman L, Girn M (2023) Psychedelic-induced mystical experiences: an interdisciplinary discussion and critique. Front Psychiatry

Muthukumaraswamy SD, Forsyth A, Lumley T (2021) Blinding and expectancy confounds in psychedelic randomized controlled trials. Expert Rev of Clin Pharmacol 14(9):1133–1152

Article  CAS  Google Scholar 

Nayak SM, Griffiths RR (2022) A single belief-changing psychedelic experience is associated with increased attribution of consciousness to living and non-living entities. Front Psychol 13:852248

Article  PubMed  PubMed Central  Google Scholar 

Nayak SM, Singh M, Yaden DB, Griffiths RR (2023) Belief changes associated with psychedelic use. J Psychopharmacol 37(1):80–92

Article  PubMed  Google Scholar 

Nichols DE (2016) Psychedelics. Pharmacol Rev 68(2):264–355

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nour MM, Evans L, Nutt D, Carhart-Harris RL (2016) Ego-dissolution and psychedelics: validation of the ego-dissolution inventory (EDI). Front Hum Neurosci 10:1–13

Article  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71

Article  PubMed  PubMed Central  Google Scholar 

Pahnke WN, Kurland AA, Goodman LE, Richards WA (1969) LSD-assisted psychotherapy with terminal cancer patients. Curr Psychiatr Ther 9:144

CAS  PubMed  Google Scholar 

Pehlivanova M, Carroll A, Greyson B (2022) Which near-death experience features are associated with reduced fear of death? Mortality 1–17

Recker GT, Peacock EJ (1981) The Life Attitude Profile (LAP): A multidimensional instrument for assessing attitudes toward life. Canadian J Behav Sci 13(3):264–273

Article  Google Scholar 

Richards WA, Grof S, Goodman LE, Kurland AA (1972) LSD-assisted psychotherapy and the human encounter with death. J Transpers Psychol

Richards WA, Rhead JC, Grof S, Goodman LE, Di Leo F, Rush L (1980) DPT as an adjunct in brief psychotherapy with cancer patients. OMEGA - J Death Dying 10(1)

Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL (2016) Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. J Psychopharmacol 30(12)

Seto E, Hicks JA, Vess M, Geraci L (2016) The association between vivid thoughts of death and authenticity. Motiv Emot 40:520–540

Article  Google Scholar 

Shim S-h (2020) The existential meaning of death and reconsidering death education through the perspectives of Kierkegaard and Heidegger. Educ Philos Theory 52(9):973–985. https://doi.org/10.1080/00131857.2020.1716334

Soares CM, Leite A, Pinto M (2023) Self-care practices with psychedelics–a qualitative study of users’ perspectives. J Psychoact Drugs 55(2):159–169

Article  Google Scholar